Skip to main content

Table 1 Clinical characteristics of studied patients

From: Uterine and placental blood flow indexes and antinuclear autoantibodies in unexplained recurrent pregnancy loss: should they be investigated in pregnancy as correlated potential factors? A retrospective study

Ā 

RPL

(nĀ =ā€‰20)

RPL

(nĀ =ā€‰24)

Controls

(nĀ =ā€‰27)

One-way ANOVA

Not-treated

LMWH-treated

Ā Ā 

ANA -

(nā€‰=ā€‰10)

ANA +

(nā€‰=ā€‰10)

ANA -

(nĀ =ā€‰10)

ANA +

(nā€‰=ā€‰14)

ANA -

(nā€‰=ā€‰11)

ANA +

(nā€‰=ā€‰16)

F

P value

Age

(years)

34Ā +Ā 5

35Ā +Ā 6

36Ā +Ā 4

35Ā +Ā 5

36Ā +Ā 2

36Ā +Ā 3

0.4

ns

BMI

(Kg/m2)

25Ā +Ā 4

26Ā +Ā 5

24Ā +Ā 4

24+ā€‰ 5

24Ā +Ā 3

26Ā +Ā 2

0.78

NS

Number of miscarriages

3Ā +Ā 0.9

3Ā +Ā 1

2.9Ā +Ā 0.8

3.1Ā +Ā 0.8

ā€“

ā€“

0.1

NS

Week of miscarriage

8.4Ā +Ā 2

8.7Ā +Ā 2.6

8.5Ā +Ā 2

9Ā +Ā 2.5

ā€“

ā€“

0.16

NS

Blood pressure

97,2 / 73,2

108,7 / 75,7

109,7 / 77,2

110,2 / 78,07

113,1 / 74,91

104,3 / 77,75

1,08/1,7

NS

gestational week of the delivery

39,1Ā +Ā 1,1

39,2Ā +Ā 1,8

39,4Ā +Ā 0,97

39,2Ā +Ā 1,48

39,9Ā +Ā 0,94

39,4Ā +Ā 1,26

0,87

NS

Birth weight

3228Ā +Ā 269,2

3308Ā +Ā 287

3436Ā +Ā 313,5

3233Ā +Ā 358,3

3279Ā +Ā 368,0

3241Ā +Ā 287,6

0,34

NS

  1. Data are expressed as MeanĀ +Ā SD or mean only
  2. ANA antinuclear antibodies; RPL recurrent pregnancy loss; BMI body mass index; NS not significant; ONE-WAY ANOVA one-way analysis of variance